Back to Search Start Over

Butamirate citrate associated methemoglobinemia

Authors :
Chung-Chih Kao
Shu-Wei Hu
Hueng-Chuen Fan
Source :
Tungs’ Medical Journal, Vol 17, Iss 2, Pp 98-101 (2023)
Publication Year :
2023
Publisher :
Wolters Kluwer Medknow Publications, 2023.

Abstract

Methemoglobinemia is a potentially life-threatening disease resulting from high blood levels of methemoglobin resulting in failure of binding and delivery of oxygen to tissues. The most common causes of methemoglobinemia are oxidizing toxins, such as butamirate citrate, which is a commonly used liquid antitussive, especially in pediatric patients. Herein, we present the case of a 3-year-old girl who accidentally ingested excessive amounts of butamirate citrate. She presented with mild lip cyanosis with high methemoglobin levels (6.5%) and normal oxygen saturation (98%), and was managed by prompt gut decontamination with activated charcoal, followed by monitoring and intravenous glucose administration. Therefore, methemoglobinemia should be considered a differential diagnosis in a patient presenting with cyanosis without any underlying lung or heart disease.

Details

Language :
English
ISSN :
20713592
Volume :
17
Issue :
2
Database :
Directory of Open Access Journals
Journal :
Tungs’ Medical Journal
Publication Type :
Academic Journal
Accession number :
edsdoj.91c4823636b64e37ab227d947447ac25
Document Type :
article
Full Text :
https://doi.org/10.4103/ETMJ.ETMJ-D-23-00020